BREAKING: Tauzin Out at PhRMA
February 12, 2010

Billy Tauzin announced on Thursday that he is stepping down as leader of PhRMA, the drug industry trade group.

Will it Matter if Pharma Turns Against the Bill?
January 16, 2010

The pharmaceutical industry is now threatening to jettison the reform bill if Democrats decide to roll back the legislation's 12-year exclusivity period for biologic drugs, as Obama is pushing for in the final negotiations. The Wall Street Journal quotes a letter that PhRMA president Billy Tauzin sent out to the trade groups members:    “Mr. Waxman is pushing hard, with the support of the President, to drop our 12-year FOB period down,” wrote Tauzin, referring to Rep. Henry Waxman, chairman of the Energy and Commerce Committee.

More on the Administration's Drug Deal
August 25, 2009

What kind of deal did the administration and Senate Finance Chairman Max Baucus make with the drug industry? And was it a good deal? I (try to) answer those questions in an article that appears in TNR's latest print edition--and is running on our (new!) home page today. As I note, albeit briefly because of the print edition's space constraints, three other articles advanced this story before I came along. One was a New York Times article, in which PhRMA chairman Billy Tauzin first spilled the beans about a key concession his group had secured.